Plunkett Research Online: Biosplice Therapeutics Inc

BIOSPLICE THERAPEUTICS INC (Private) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Biosplice Therapeutics, Inc. is pioneering first-in-class, small-molecule therapeutics based on CLK/DYRK kinase modulation. The company’s small molecule-based Wnt platform has revealed novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative pre-mRNA splicing, as well as .....


BIOSPLICE THERAPEUTICS INC

Ticker: Private
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 858-926-2900
Fax:
Address: 9360 Towne Centre Dr.
San Diego, CA 92121 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Cevdet Samikoglu CEO
Erich Horsley CFO
See More
Biosplice Therapeutics, Inc. is pioneering first-in-class, small-molecule therapeutics based on CLK/DYRK kinase modulation. The company’s small molecule-based Wnt platform has revealed novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative pre-mRNA splicing, as well as .....See More See More

$USD, In whole numbers 2020 2019 2018 2017 2016 2015 2014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture